1. Genkins G, Kornfeld P, Papatestas AE, et al.: Clinical experience in more than 2,000 patients with myasthenia gravis. Ann N Y Acad Sci 1987, 505:500–513.
2. Dalakas MC: Polymyositis, dermatomyositis, and inclusion body myositis. N Engl J Med 1991, 325:1487–1498.
3. Sibley WA, Bamford CR, Clark K: Triggering factors in multiple sclerosis. In Diagnosis of Multiple Sclerosis. Edited by Poser CM, Paty DW, Scheinberg L. New York: Thieme-Stratton; 1984:14.
4. Constantinescu CS, Cohen JA: Regulatory-cytokine therapy for autoimmune diseases: implications for multiple sclerosis. Multiple Sclerosis: Clinical Issues 1994, 1:6–9.
5. Glaser JS: Topical diagnosis: prechiasmal visual pathways. In Neuroophthalmology, edn 2. Edited by Glaser JS. Philadelphia: JB Lippincott; 1990:123–128.